Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AMGN | VRTX | BMY | GILD |
| Company | Celldex Therapeutics | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 25.34 | 316.16 | 483.00 | 55.14 | 89.64 |
| High | 25.72 | 319.52 | 503.20 | 56.28 | 90.39 |
| Low | 24.43 | 313.02 | 474.00 | 54.72 | 89.01 |
| Last | 25.43 | 319.29 | 499.88 | 55.95 | 90.22 |
| Change | +0.04 | +2.38 | +27.08 | +0.50 | +0.38 |
| % Change | +0.16% | +0.75% | +5.73% | +0.90% | +0.42% |
| Volume | 1,303,300 | 1,472,300 | 1,723,200 | 9,278,000 | 3,960,200 |
| 20-Day Average Volume | 951,160 | 1,722,060 | 1,072,950 | 8,714,770 | 5,156,835 |
| Previous Close | 25.39 | 316.91 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.12 | 319.72 | 478.91 | 53.23 | 87.52 |
| 20-Day Raw Stochastic | 13.83% | 46.71% | 92.94% | 93.36% | 92.51% |
| 20-Day Relative Strength | 31.11% | 48.10% | 60.80% | 64.02% | 69.82% |
| Weighted Alpha | -33.39 | +16.76 | +32.73 | +18.27 | +27.65 |
| Today's Opinion | 100% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.32% since 10/29/24 | +1.04% since 10/29/24 | +6.28% since 10/29/24 | +6.57% since 10/29/24 | +2.43% since 10/29/24 |
| Low | 24.43 on 11/05/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 27.37 on 10/30/24 | 323.40 on 10/31/24 | 503.20 on 11/05/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | -17.03% since 10/04/24 | -0.12% since 10/04/24 | +9.79% since 10/04/24 | +3.69% since 10/04/24 | +6.66% since 10/04/24 |
| Low | 24.43 on 11/05/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 31.66 on 10/14/24 | 329.17 on 10/11/24 | 503.20 on 11/05/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | -22.28% since 08/05/24 | -1.82% since 08/05/24 | +4.82% since 08/05/24 | +17.57% since 08/05/24 | +20.57% since 08/05/24 |
| Low | 24.43 on 11/05/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 47.00 on 09/25/24 | 339.17 on 09/23/24 | 503.20 on 11/05/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | -40.25% since 05/03/24 | +2.57% since 05/03/24 | +24.63% since 05/03/24 | +27.19% since 05/03/24 | +39.27% since 05/03/24 |
| Low | 24.43 on 11/05/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 47.00 on 09/25/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,685,704 | 171,628,928 | 129,020,016 | 113,476,496 | 112,323,168 |
| Shares Outstanding, K | 66,288 | 537,533 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 6,880,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -141,430,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 2,500,000 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -35,840,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 1.60 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 08/08/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.49 | 0.00 | 47.39 | 19.11 |